Regional Program in collaboration with UCSF Helen Diller Family Comprehensive Cancer Center
Saturday, December 14, 2013
Fisher Banquet Room, Mission Bay Conference Center, UCSF
San Francisco, CA
Presentations included allotted time for Audience Response System (ARS) assisted audience interaction as well as general question and answer time. |
|
7:00 am - 8:00 am | Registration |
7:00 am - 8:00 am | Continental Breakfast |
8:00 am - 8:10 am | Welcome and Introductions Lawrence Fong, MD - University of California San Francisco |
8:10 am - 8:35 am | Immunology 101 for the Practicing Oncologist Aaron Logan, MD, PhD - University of California San Francisco |
8:35 am - 9:00 am | What You Need to Know about Innate Immunity Jeffrey M. Venstrom, MD - University of California San Francisco |
9:00 am - 9:25 am | Cytokine Therapy: Lessons Learned and Novel Agents Adil Daud, MD - University of California San Francisco |
9:25 am - 9:40 am | Break |
9:40 am - 10:15 am | Sipuleucel-T and Other Vaccines as Immunotherapy Lawrence Fong, MD - University of California San Francisco |
10:15 am - 10:50 am | Ipilimumab: Indications and Clinical Management Alain Algazi, MD - University of California San Francisco |
10:50 am - 11:25 am | Anti-PD-1 and Anti-PD-L1 Therapy Antoni Ribas, MD, PhD - University of California Los Angeles |
11:25 am - 12:00 pm | The Emerging Role of Combination Tumor Immunotherapy Holbrook E. Kohrt, MD, PhD - Stanford Cancer Institute |
12:00 pm - 12:55 pm | Lunch |
12:55 pm - 1:20 pm | Immunotherapy: The Need for Immune Monitoring and Development of Predictive Markers Lawrence Fong, MD - University of California San Francisco |
1:20 pm - 1:55 pm | Adoptive T-cell Transfer as an Anti-tumor Approach Antoni Ribas, MD, PhD - University of California Los Angeles |
1:55 pm - 2:55 pm | Keynote: Normal and Neoplastic Stem Cells Irving L. Weissman, MD - Stanford University |
2:55 pm - 3:00 pm | Closing Remarks Antoni Ribas, MD, PhD - University of California Los Angeles |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.